[ASCO-Update 2005--Highlights of the 41st Meeting of the American Society of Clinical Oncology/ASCO 2005].
Currently, the treatment of gastrointestinal cancers is rapidly changing due to the implementation of novel chemotherapeutic agents as well as the introduction of targeted therapies into treatment protocols. The following review provides an overview of the most important clinical trials in esophageal, gastric, colorectal, pancreatic and hepatobiliary cancer that were presented at the annual meeting of the American Society of Clinical Oncology.
Höhler
T
T
Prosper Hospital Recklinghausen, Recklinghausen.
Heike
M
M
Lutz
M P
MP
Graeven
U
U
Seufferlein
T
T
D002986:Clinical Trials as Topic / Q000639:trends*; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008495:Medical Oncology / Q000379:methods* / Q000639:trends*; D012955:Societies, Medical / Q000458:organization & administration*; D014481:United States